| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-17 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 7e-15 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.32 | 1e-11 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |